Safety and Performance Study of TIGR Matrix Surgical Mesh in Inguinal Hernia Repair
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Frequency of Adverse Events or Serious Adverse Events
研究概览
简要总结
This an open, uncontrolled multicenter clinical study to assess the safety and performance of the WK-6 surgical mesh in adult patients with unilateral inguinal hernia.
The primary objective is to determine the safety of the WK-6 surgical mesh. Data will be compared retrospectively with published studies on inguinal hernia mesh.
The secondary objectives are to explore the performance of the surgical mesh by measuring the pain pre and post surgery as well as a number of relevant variables for establishing the performance of the mesh. Data will be compared retrospectively with previous studies on inguinal hernia mesh with a follow-up of at least one year.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Patients who have given informed consent
- •Male, 18 years and older.
- •Patients with primary unilateral inguinal hernia
- •Planned surgery procedure according to Lichtenstein technique
排除标准
- •Patients who are unwilling and/or unable to give informed consent
- •Hernia strangulated or irreducible
- •Recurrent Hernia
- •Previous mesh surgery on the same side
- •Class >IIa patients
- •Unable to walk 500 meters
- •BMI >30 kg/m2
- •Warfarin treatment, ongoing or within two weeks of surgery.
- •Peripheral artery disease
- •Chronic back pain, as judged by the investigator.
- •Hip joint arthrosis
- •Hypermobility syndrome, as judged by the investigator.
- •Constipation
- •Drug or alcohol abuse
- •COPD (chronic obstructive pulmonary disease)
- •Patients at increased risk of death from a pre-existing concurrent illness
- •Patients participating in another clinical study
- •Patients who have used any other investigational drug or device within 1 month
- •Patients who cannot communicate reliably with the investigator
- •Patients who are unlikely to cooperate with the requirements of the study
- •Patients who are employees at the investigational site; relatives or spouse of the PI.
- •Patients not suitable based upon investigator decision
结局指标
主要结局
Frequency of Adverse Events or Serious Adverse Events
时间窗: 12 months
Safety is assessed by monitoring the incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs) related and unrelated to the mesh and rehabilitation. AEs and SAEs will be collected during surgery and throughout the follow up period. Possible adverse reactions with the use of any prosthesis may include but are not limited to infection, inflammation, extrusion, dhesion, fistula formation, seroma formation, hematoma, and recurrence of the hernia or tissue defect.
次要结局
- Pain(12 months)